NEW YORK (360Dx) – Vermillion reported after the close of the market on Monday an 11 percent year-over-year drop in first quarter revenues.

For the three months ended March 31, the Austin, Texas-based cancer diagnostics firm said that total revenues fell to $649,000 from $728,000 in the year-ago quarter.

Product revenues were $613,000, down from $678,000 in Q1 2017. Service revenues were $36,000, down from $48,000 the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.